1. Home
  2. FATE vs NCSM Comparison

FATE vs NCSM Comparison

Compare FATE & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.99

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$52.55

Market Cap

112.0M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
NCSM
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
112.0M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
FATE
NCSM
Price
$1.99
$52.55
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
4.3M
29.2K
Earning Date
05-14-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
29.88
239.22
EPS
N/A
N/A
Revenue
$6,646,000.00
$142,471,000.00
Revenue This Year
N/A
$5.57
Revenue Next Year
N/A
$4.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$28.73
52 Week High
$2.88
$87.36

Technical Indicators

Market Signals
Indicator
FATE
NCSM
Relative Strength Index (RSI) 48.64 50.69
Support Level $1.00 $35.60
Resistance Level $2.88 $53.69
Average True Range (ATR) 0.21 2.44
MACD -0.06 0.66
Stochastic Oscillator 16.04 64.93

Price Performance

Historical Comparison
FATE
NCSM

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: